• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无法分类的间质性肺疾病的患病率和预后。

Prevalence and prognosis of unclassifiable interstitial lung disease.

机构信息

Dept of Medicine, University of British Columbia, Vancouver, BC, Canada.

出版信息

Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.

DOI:10.1183/09031936.00131912
PMID:23222877
Abstract

The aim of this study was to determine the prevalence, characteristics and outcomes of patients with unclassifiable interstitial lung disease (ILD) and to develop a simple method of predicting disease behaviour. Unclassifiable ILD patients were identified from an ongoing longitudinal cohort. Unclassifiable ILD was diagnosed after a multidisciplinary review did not secure a specific ILD diagnosis. Clinical characteristics and outcomes were compared with idiopathic pulmonary fibrosis (IPF) and non-IPF ILDs. Independent predictors of mortality were determined using Cox proportional-hazards analysis to identify subgroups with distinct disease behaviour. Unclassifiable ILD was diagnosed in 10% of the ILD cohort (132 out of 1370 patients). The most common reason for being unclassifiable was missing histopathological assessment due to a high risk of surgical lung biopsy. Demographic and physiological features of unclassifiable ILD were intermediate between IPF and non-IPF disease controls. Unclassifiable ILD had longer survival rates when compared to IPF on adjusted analysis (hazard ratio 0.62, p = 0.04) and similar survival compared to non-IPF ILDs (hazard ratio 1.54, p = 0.12). Independent predictors of survival in unclassifiable ILD included diffusion capacity of the lung for carbon monoxide (p = 0.001) and a radiological fibrosis score (p = 0.02). Unclassifiable ILD represents approximately 10% of ILD cases and has a heterogeneous clinical course, which can be predicted using clinical and radiological variables.

摘要

本研究旨在确定无法分类的间质性肺疾病(ILD)患者的患病率、特征和结局,并开发一种简单的预测疾病行为的方法。无法分类的ILD 患者是从正在进行的纵向队列中确定的。在多学科审查未能确定特定的ILD 诊断后,诊断为无法分类的ILD。比较了无法分类的ILD 与特发性肺纤维化(IPF)和非 IPFILD 的临床特征和结局。使用 Cox 比例风险分析确定死亡率的独立预测因素,以确定具有不同疾病行为的亚组。在 1370 名ILD 患者中,10%(132 名)被诊断为无法分类的ILD。无法分类的最常见原因是由于手术肺活检风险高而缺少组织病理学评估。无法分类的ILD 的人口统计学和生理学特征在 IPF 和非 IPF 疾病对照之间处于中间位置。调整分析显示,与 IPF 相比,无法分类的ILD 的生存率更高(风险比 0.62,p = 0.04),与非 IPFILD 的生存率相似(风险比 1.54,p = 0.12)。无法分类的ILD 的生存独立预测因素包括肺一氧化碳弥散量(p = 0.001)和影像学纤维化评分(p = 0.02)。无法分类的ILD 占ILD 病例的 10%左右,具有异质性的临床过程,可使用临床和影像学变量进行预测。

相似文献

1
Prevalence and prognosis of unclassifiable interstitial lung disease.无法分类的间质性肺疾病的患病率和预后。
Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.
2
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.一项针对丹麦间质性肺疾病患者的队列研究:负担、严重程度、治疗与生存情况。
Dan Med J. 2015 Apr;62(4):B5069.
3
Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.无法分类的间质性肺疾病的临床特征:与慢性纤维化性特发性间质性肺炎的比较。
J Int Med Res. 2018 Jan;46(1):448-456. doi: 10.1177/0300060517719767. Epub 2017 Jul 31.
4
Unclassifiable interstitial lung diseases: Clinical characteristics and survival.无法分类的间质性肺疾病:临床特征和生存情况。
Respirology. 2017 Apr;22(3):494-500. doi: 10.1111/resp.12931. Epub 2016 Nov 6.
5
A cohort study of interstitial lung diseases in central Denmark.丹麦中部间质性肺疾病的队列研究。
Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20.
6
Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.通过高分辨率计算机断层扫描评估的肺气肿对经外科肺活检诊断的特发性肺纤维化的临床影响。
Respiration. 2016;92(4):220-228. doi: 10.1159/000448118. Epub 2016 Aug 31.
7
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.计算机断层扫描蜂巢征鉴别不同间质性肺疾病中具有进展性纤维化表型的患者,此类患者的死亡率更高。
Ann Am Thorac Soc. 2019 May;16(5):580-588. doi: 10.1513/AnnalsATS.201807-443OC.
8
Challenges in the classification of fibrotic ILD.纤维化间质性肺疾病分类中的挑战。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9.
9
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?风险预测模型对评估类风湿关节炎相关间质性肺疾病患者的生存率有用吗?
BMC Pulm Med. 2017 Jan 13;17(1):16. doi: 10.1186/s12890-016-0358-2.
10
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.非对称性特发性肺纤维化患者的临床特征
Respir Med. 2016 Oct;119:96-101. doi: 10.1016/j.rmed.2016.08.028. Epub 2016 Aug 31.

引用本文的文献

1
Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases.间质性肺疾病的病理生理见解与临床管理策略
Biomol Ther (Seoul). 2025 Sep 1;33(5):785-803. doi: 10.4062/biomolther.2025.003. Epub 2025 Aug 14.
2
Progressive pulmonary fibrosis: current perspectives in diagnostic imaging.进行性肺纤维化:诊断成像的当前观点
BJR Open. 2025 Jul 24;7(1):tzaf018. doi: 10.1093/bjro/tzaf018. eCollection 2025 Jan.
3
Spatial transcriptomics identifies SPARC as a prognostic marker in interstitial lung diseases.
空间转录组学确定SPARC为间质性肺疾病的预后标志物。
J Pathol. 2025 Sep;267(1):79-91. doi: 10.1002/path.6451. Epub 2025 Jul 28.
4
A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.进行性肺纤维化的定量成像测量
Am J Respir Crit Care Med. 2025 Jul 18. doi: 10.1164/rccm.202501-0208OC.
5
Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease.急性加重和普通型间质性肺炎在纤维化间质性肺疾病中的预后意义
Sci Rep. 2025 Jul 1;15(1):21580. doi: 10.1038/s41598-025-08969-1.
6
[Target organ the lungs: diversity of fibrotic pulmonary diseases].[目标器官——肺:纤维化肺部疾病的多样性]
Inn Med (Heidelb). 2025 Jun 24. doi: 10.1007/s00108-025-01911-7.
7
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion.多学科讨论后间质性肺疾病的诊断和预后轨迹
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323487. doi: 10.1177/17534666251323487. Epub 2025 Mar 13.
8
Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review.进行性肺纤维化的流行病学与预后:文献综述
Pulm Ther. 2025 Jun 16. doi: 10.1007/s41030-025-00302-5.
9
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.新冠后肺部残留异常患者的呼吸道微生物群与健康个体相似,且与特发性肺纤维化不同。
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00826-2024. eCollection 2025 May.
10
Treatable traits in interstitial lung disease: a narrative review.间质性肺疾病的可治疗特征:一篇叙述性综述
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251335774. doi: 10.1177/17534666251335774. Epub 2025 May 3.